Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.005 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: a randomised controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.
2016Effect of duodenal glucose load on blood pressure in type 2 diabetesMarathe, C.; Horowitz, M.; Trahair, L.; Bound, M.; Checklin, H.; Lange, K.; Rayner, C.; Jones, K.
2016A whey/guar "preload" improves postprandial glycaemia and HbA(1c) in type 2 diabetes: a 12-week, single-blind, randomised and placebo controlled trialMignone, L.; Wu, T.; Phillips, L.; Bound, M.; Checklin, H.; Grivell, J.; Jones, K.; Clifton, P.; Horowitz, M.; Rayner, C.; 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD) (12 Sep 2016 - 16 Sep 2016 : Munich, GERMANY)
2016Comparative effects of proximal and distal small intestinal glucose on glycaemia, incretin hormone secretion and incretin effect in healthy malesZhang, X.; Bound, M.; Standfield, S.; Hu, S.; Jones, K.; Horowitz, M.; Rayner, C.; Wu, T.; 52nd Annual Meeting of the European Association for the Study of Diabetes (EASD) (12 Sep 2016 - 16 Sep 2016 : Munich, GERMANY)
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.
2016A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetesWu, T.; Little, T.; Bound, M.; Borg, M.; Zhang, X.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2016Small intestinal glucose delivery affects the lowering of blood glucose by acute vildagliptin in type 2 diabetesWu, T.; Zhang, X.; Trahair, L.; Bound, M.; Little, T.; Deacon, C.; Horowitz, M.; Jones, K.; Rayner, C.
2016Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trialThazhath, S.; Wu, T.; Bound, M.; Checklin, H.; Standfield, S.; Jones, K.; Horowitz, M.; Rayner, C.